Severity: Warning
Message: fopen(/var/lib/php/sessions/ci_sessionaacgk83nethdsugl5b9nbh3esoatd6ts): Failed to open stream: No space left on device
Filename: drivers/Session_files_driver.php
Line Number: 177
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Severity: Warning
Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)
Filename: Session/Session.php
Line Number: 137
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Nan Fang Yi Ke Da Xue Xue Bao
Department of Pathology and Pathophysiology, School of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Published: January 2021
Objective: To investigate the therapeutic mechanism of resveratrol (RES) for Alzheimer's disease (AD) in light of network pharmacology.
Methods: We searched PubChem, BATMAN-TCM, Genecards, AD, TTD, String 11.0, AlzData, SwissTargetPrediction, Metascape and other databases for the therapeutic targets of RES and human AD-related targets. The intersection was determined using Venny 2.1 to obtain the therapeutic targets of RES for AD. The protein-protein interaction (PPI) network was constructed, the gene ontology (GO) was enriched and the Kyoto Encyclopedia of Genes and Genomes pathway (KEGG pathway) were analyzed. Cytoscape 3.7.1 software was used to construct a target-signaling pathway network of RES in the treatment of AD. Molecular docking verification was carried out on SwissDock (http://www.swissdock.ch/docking). We examined a 293Tau cell model of AD for changes in protein levels of pS396, pS199, Tau5, CDK5, glycogen synthase kinase 3β (GSK3β) and p-GSK3β in response to RES treatment using Western blotting.
Results: We obtained 182 targets of RES, 525 targets related to AD, and 36 targets of RES for AD treatment, among which 34.6% of the targets were protein-modifying enzymes, 27.7% were metabolite invertase, 13.8% were gene-specific transcriptional regulators, and 10.3% were transporters. The core key targets of RES in the treatment of AD included INS, APP, ESR1, MMP9, IGF1R, CACNA1C, MAPT (microtubule- associated protein Tau), MMP2, TGFB1 and GSK3B. Enrichment analysis of GO biological process suggested that the biological function of RES in AD treatment mainly involved the response to β-amyloid protein, positive regulation of transferase activity, the transmembrane receptor protein tyrosine kinase signaling pathway, regulation of behavior, learning or memory, aging, and transmembrane transport. KEGG pathway enrichment analysis showed that the most significantly enriched signaling pathways were AD pathway, PI3K-AKT signaling pathway, cGMP-PKG signaling pathway, and MAPK signaling pathway. Molecular docking results showed that RES had strong binding with ESR1, GSK3B, MMP9, IGF1R, APP and INS. In the cell model of AD, treatment with 50 μmol/L RES for 12 h significantly reduced the levels of pS396 and pS199 by regulating CDK5 and GSK3β activity ( < 0.001).
Conclusions: RES produces therapeutic effects on AD by acting on multiple targets and affecting multiple signaling pathways and improves AD-associated pathologies a direct action on Aβ and Tau pathological processes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867487 | PMC |
http://dx.doi.org/10.12122/j.issn.1673-4254.2021.01.02 | DOI Listing |
Nicotine Tob Res
March 2025
Department of Population and Public Health Sciences, Keck School of Medicine of the University of Southern California, Los Angeles, CA, United States.
Introduction: The objective of this study was to examine the mechanisms of social influence driving e-cigarette use in adolescent social networks and differentiate between the effects of exposure to friend behavior and social norms on individual use.
Methods: Surveys on health behaviors and friendship networks from nine high schools in Southern California (N = 2,245; 48% Hispanic) were collected at three time points from Spring 2021 of grade 9, Fall 2021, and Spring 2022 of grade 10. Stochastic actor-oriented models for the co-evolution of social networks and behavior dynamics tested for friendship network social influences on e-cigarette use.
Breast Cancer Res
March 2025
Federal University of Pará, R. Augusto Corrêa, Guamá, nº01, Belem, PA, 66075-110, Brazil.
Background: Currently, the primary methods for detecting HER2 expression levels are immunohistochemistry (IHC) and in situ hybridization (ISH), with the traditional standard being a HER2-positive score of 3 + accompanied by ERBB2 gene amplification detected through ISH. However, a new entity has recently emerged: HER2-low, defined as HER2 IHC 1 + or 2 + with negative ISH. HER2-low breast cancer, representing 45-60% of all HER2-negative tumors, has distinct biological characteristics and uncertain responses to conventional HER2-targeted therapies.
View Article and Find Full Text PDFEur J Med Res
March 2025
Department of Internal Medicine, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, 138 Sheng Li Road, Tainan, Taiwan.
Objective: Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors are a standard therapy for patients who respond poorly to or cannot tolerate statins. However, identifying responders to PCSK9 inhibitors remains unclear. This study investigates the characteristics of patients who achieve target LDL-C reduction (< 70 mg/dl) after PCSK9 inhibitor therapy.
View Article and Find Full Text PDFBMC Health Serv Res
March 2025
School of Public Health, The University of Queensland, Brisbane, Australia.
Introduction: Multimorbidity amplifies healthcare burdens due to the intricate requirements of patients and the pathophysiological complexities of multiple diseases. To address this, digital health technologies play a crucial role in effective healthcare delivery, requiring comprehensive evidence on their applications in managing multimorbidity. Therefore, this scoping review aims to identify various types of digital health technologies, explore their mechanisms, and identify barriers and facilitators within the context of multimorbidity.
View Article and Find Full Text PDFBMC Vet Res
March 2025
Department of Animal Science and Technology, Sunchon National University, 255 Jungang-ro, Suncheon-si, Jeollanam-do, 57922, South Korea.
Background: This study investigated the prevalence of hoof disorders (HDs) in intensive dairy farms in Korea and their association with farm conditions. A total of 877 cattle from 15 farms were examined for infectious, noninfectious, and non-lesion HDs at the animal, foot, and farm levels. Risk factors such as bedding depth, floor wetness, floor elevation transitions, and aggressive hoof treatment were evaluated.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.